Objective: To identify risk factors associated with the development of post-traumatic retained hemothorax in chest trauma patients admitted to Hospital San Vicente de Paul (HUSVP).
Methods: This study was a prospective cohort study that included patients with a diagnosis of chest trauma who required a tube thoracostomy as a therapeutic intervention. The measured outcome was retained hemothorax, defined as the presence of blood in the pleural cavity that could not be drained through the initial tube thoracostomy and appeared radio-opaque or hypodense on X-rays or CT scan. The postoperative follow-up period was 30 days.
Results: Six hundred thirty-three thoracostomies were performed over a 28-month period for chest trauma; the incidence of post-traumatic retained hemothorax was 16.7%, and additional complications were seen in 10% of cases. The risk of retained hemothorax was associated with: initial blood drainage (median, 400 ml; p < 0.001), the number of tubes placed (two or more; OR = 5.35, CI 95%: 3.98-7.20), the duration of the tube thoracostomy (median, 5 days; p = 0.01), and the need for mechanical ventilation (RR = 2.5, CI 95%: 1.66-3.75).
Conclusions: The risk of post-traumatic retained hemothorax was associated with four factors. The probability of the outcome could be modified by careful monitoring, management protocols, suction through the tube thoracostomy, and maybe an early intervention, such as thoracoscopy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00068-010-0064-3 | DOI Listing |
Cureus
November 2024
Cardiothoracic Surgery, Northeast Georgia Medical Center Gainesville, Gainesville, USA.
Hemothorax is a serious complication following thoracic surgery, often resulting from vessel injury or rib fractures, and is typically managed with chest tube drainage. Persistent or loculated hemothorax, referred to as retained hemothorax, may require more invasive interventions, such as thoracotomy. Although the intrapleural administration of tissue plasminogen activator (tPA) and deoxyribonuclease (DNase) has shown promise in managing pleural infections, its use for hemothorax remains controversial due to bleeding risks.
View Article and Find Full Text PDFJ Surg Res
December 2024
Department of Surgery, College of Medicine, University of Cincinnati, Cincinnati, Ohio. Electronic address:
Introduction: Thoracobiliary fistula (TBF) is a rare and highly morbid complication of hepatic trauma. There is a paucity of literature regarding incidence, disease course, and treatment. This study identifies etiologic factors and outcome patterns in patients at risk for TBF.
View Article and Find Full Text PDFJ Trauma Acute Care Surg
February 2025
From the Divisions of Trauma, Surgical Critical Care, and Burns, DeWitt Daughtry Family Department of Surgery, Ryder Trauma Center, University of Miami Miller School of Medicine, Miami, Florida.
Injury
January 2025
Department of General Surgery, All India Institute of Medical Sciences, Jodhpur, India. Electronic address:
J Trauma Acute Care Surg
October 2024
From the Divisions of Trauma, Surgical Critical Care, and Burns, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Ryder Trauma Center, Miami, Florida.
Background: Traumatic hemothorax (HTX) is common, and while it is recommended to drain it with a tube thoracostomy, there is no consensus on the optimal catheter size. We performed a systematic review to test the hypothesis that small bore tube thoracostomy (SBTT) (≤14 F) is as effective as large-bore tube thoracostomy (LBTT) (≥20F) for the treatment of HTX.
Methods: Pubmed, EMBASE, Scopus, and Cochrane review were searched from inception to November 2022 for randomized controlled trials or cohort studies that included adult trauma patients with HTX who received a tube thoracostomy.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!